Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10816062rdf:typepubmed:Citationlld:pubmed
pubmed-article:10816062lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:10816062lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:10816062lifeskim:mentionsumls-concept:C0027051lld:lifeskim
pubmed-article:10816062lifeskim:mentionsumls-concept:C0034656lld:lifeskim
pubmed-article:10816062lifeskim:mentionsumls-concept:C0681867lld:lifeskim
pubmed-article:10816062lifeskim:mentionsumls-concept:C0001645lld:lifeskim
pubmed-article:10816062lifeskim:mentionsumls-concept:C0015259lld:lifeskim
pubmed-article:10816062lifeskim:mentionsumls-concept:C0220931lld:lifeskim
pubmed-article:10816062lifeskim:mentionsumls-concept:C0023983lld:lifeskim
pubmed-article:10816062pubmed:issue1lld:pubmed
pubmed-article:10816062pubmed:dateCreated2000-7-14lld:pubmed
pubmed-article:10816062pubmed:abstractTextIn this study we assessed the short- and long-term effects of 4-weeks of exercise training (MI) soon after myocardial infarction in patients on beta-blocker treatment. Thirty-seven male patients < or = 65 years of age were included in the study, 19 of them randomized to exercise training (ET) and 18 to a control group (Ctr). Cumulated work (CW), calculated in kiloJoules (kJ), was recorded before immediately after the intervention period and again six months after the MI. In the short term the mean (SD) CW increased by 22% (from 65(20) to 79(25) kJ) in the ET group, compared with no change in the Ctr patients (65(24) vs 65(21) kJ) (p = 0.009). At late follow-up CW was 14% above baseline in the ET patients (65(20) vs 74(20) kJ) p = 0.036, compared with only 6% in the 15 Ctr patients who were still available for follow-up (68(24) vs 72(29) kJ), but without a significant between-group difference. In post-MI patients on beta-blocker treatment, and with a high baseline exercise capacity, physical training improved exercise capacity in the short term, but there was no significant between-group difference at long-term follow-up.lld:pubmed
pubmed-article:10816062pubmed:languageenglld:pubmed
pubmed-article:10816062pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10816062pubmed:citationSubsetIMlld:pubmed
pubmed-article:10816062pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10816062pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10816062pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10816062pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10816062pubmed:statusMEDLINElld:pubmed
pubmed-article:10816062pubmed:issn1401-7431lld:pubmed
pubmed-article:10816062pubmed:authorpubmed-author:SireSSlld:pubmed
pubmed-article:10816062pubmed:authorpubmed-author:DaleJJlld:pubmed
pubmed-article:10816062pubmed:authorpubmed-author:HeldalMMlld:pubmed
pubmed-article:10816062pubmed:issnTypePrintlld:pubmed
pubmed-article:10816062pubmed:volume34lld:pubmed
pubmed-article:10816062pubmed:ownerNLMlld:pubmed
pubmed-article:10816062pubmed:authorsCompleteYlld:pubmed
pubmed-article:10816062pubmed:pagination59-64lld:pubmed
pubmed-article:10816062pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:10816062pubmed:meshHeadingpubmed-meshheading:10816062...lld:pubmed
pubmed-article:10816062pubmed:meshHeadingpubmed-meshheading:10816062...lld:pubmed
pubmed-article:10816062pubmed:meshHeadingpubmed-meshheading:10816062...lld:pubmed
pubmed-article:10816062pubmed:meshHeadingpubmed-meshheading:10816062...lld:pubmed
pubmed-article:10816062pubmed:meshHeadingpubmed-meshheading:10816062...lld:pubmed
pubmed-article:10816062pubmed:meshHeadingpubmed-meshheading:10816062...lld:pubmed
pubmed-article:10816062pubmed:meshHeadingpubmed-meshheading:10816062...lld:pubmed
pubmed-article:10816062pubmed:meshHeadingpubmed-meshheading:10816062...lld:pubmed
pubmed-article:10816062pubmed:meshHeadingpubmed-meshheading:10816062...lld:pubmed
pubmed-article:10816062pubmed:meshHeadingpubmed-meshheading:10816062...lld:pubmed
pubmed-article:10816062pubmed:meshHeadingpubmed-meshheading:10816062...lld:pubmed
pubmed-article:10816062pubmed:meshHeadingpubmed-meshheading:10816062...lld:pubmed
pubmed-article:10816062pubmed:meshHeadingpubmed-meshheading:10816062...lld:pubmed
pubmed-article:10816062pubmed:meshHeadingpubmed-meshheading:10816062...lld:pubmed
pubmed-article:10816062pubmed:meshHeadingpubmed-meshheading:10816062...lld:pubmed
pubmed-article:10816062pubmed:meshHeadingpubmed-meshheading:10816062...lld:pubmed
pubmed-article:10816062pubmed:meshHeadingpubmed-meshheading:10816062...lld:pubmed
pubmed-article:10816062pubmed:year2000lld:pubmed
pubmed-article:10816062pubmed:articleTitleRandomised training after myocardial infarction: short and long-term effects of exercise training after myocardial infarction in patients on beta-blocker treatment. A randomized, controlled study.lld:pubmed
pubmed-article:10816062pubmed:affiliationDepartment of Cardiology, Aker University Hospital, Oslo, Norway. magnus.heldal@ioks.uio.nolld:pubmed
pubmed-article:10816062pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10816062pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:10816062pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:10816062pubmed:publicationTypeRandomized Controlled Triallld:pubmed